DSC Advisors’s Immunic IMUX Stock Holding History

DSC Advisors’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-112	Closed	-$1.12M	–	80
2015 Q1	$1.12M	Buy	+112	New	+$1.03M	0.6%	35

Other funds holding IMUX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

DSC Advisors's IMUX Position: Q2 2015 in Review

DSC Advisors sold out of Immunic (IMUX) in Q2 2015, closing a stake of 112 shares — an estimated $1.12M sold.

DSC Advisors first reported a position in IMUX in Q1 2015 and held it in 1 quarter. The position peaked at $1.12M in Q1 2015. 52 funds tracked by Wall St. Rank hold IMUX as of Q2 2015.

DSC Advisors reported no remaining Immunic position as of Q2 2015 after selling out during the quarter.
DSC Advisors sold 112 Immunic shares in Q2 2015, an estimated $1.12M.
DSC Advisors first reported a position in Immunic in Q1 2015 and held it in 1 quarter.
DSC Advisors's Immunic position peaked at $1.12M in Q1 2015.
52 funds tracked by Wall St. Rank held Immunic as of Q2 2015.

Based on DSC Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.